Linked e-resources
Details
Table of Contents
Part I The region
Part II The health system
2.1. Building blocks
2.2. Universal health coverage
2.3. Sustainable development goals
2.4. Integrated people centric eye care
2.5. Public financing
2.6. Health management and information
Part III The problem
3.1. Disease burden
3.2. RAAB and population studies
Part IV Common disorders
4.1. Cataract
4.2. Refractive error and school eye health
4.3. Childhood blindness and VI
4.4. NCD and diabetic retinopathy
4.5. NTD and trachoma
4.6. Glaucoma
4.7. Cornea and eye banking
4.8. Low vision
Part V Workforce, training and education
5.1. Ophthalmology
5.2. Optometry
5.3. Allied ophthalmic personnel
Part VI International NGOs
6.1. CBM
6.2. Combat blindness international
6.3. Essilor foundation
6.4. Fred hollows
6.5. Helen keller International
6.6. Himalayan cataract
6.7. Mission for vision
6.8. OEU
6.9. Orbis
6.10. Seva foundation
6.11. Sight savers
6.12. Vision spring
Part VII Ophthalmic industry
7.1. Spectacles
7.2. Ophthalmic devices and equipment
7.3. Pharma industry.
Part II The health system
2.1. Building blocks
2.2. Universal health coverage
2.3. Sustainable development goals
2.4. Integrated people centric eye care
2.5. Public financing
2.6. Health management and information
Part III The problem
3.1. Disease burden
3.2. RAAB and population studies
Part IV Common disorders
4.1. Cataract
4.2. Refractive error and school eye health
4.3. Childhood blindness and VI
4.4. NCD and diabetic retinopathy
4.5. NTD and trachoma
4.6. Glaucoma
4.7. Cornea and eye banking
4.8. Low vision
Part V Workforce, training and education
5.1. Ophthalmology
5.2. Optometry
5.3. Allied ophthalmic personnel
Part VI International NGOs
6.1. CBM
6.2. Combat blindness international
6.3. Essilor foundation
6.4. Fred hollows
6.5. Helen keller International
6.6. Himalayan cataract
6.7. Mission for vision
6.8. OEU
6.9. Orbis
6.10. Seva foundation
6.11. Sight savers
6.12. Vision spring
Part VII Ophthalmic industry
7.1. Spectacles
7.2. Ophthalmic devices and equipment
7.3. Pharma industry.